Dyne Therapeutics (DYN) Insider Trading & Ownership $10.32 -0.46 (-4.27%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.52 +0.21 (+1.99%) As of 06/20/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dyne Therapeutics (NASDAQ:DYN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.77%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.06MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$6.74M Get DYN Insider Trade Alerts Want to know when executives and insiders are buying or selling Dyne Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DYN Insider Buying and Selling by Quarter Dyne Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/13/2025Johanna Friedl-NadererInsiderSell143$12.12$1,733.16 3/11/2025Oxana BeskrovnayaInsiderSell2,153$11.38$24,501.14 3/11/2025Richard William ScalzoSVPSell1,343$11.38$15,283.34 2/18/2025Oxana BeskrovnayaInsiderSell2,598$13.95$36,242.10 12/11/2024Oxana BeskrovnayaInsiderSell2,334$28.12$65,632.08 12/11/2024Richard William ScalzoSVPSell1,455$28.12$40,914.60 11/18/2024Carlo IncertiDirectorSell16,500$28.73$474,045.00 11/14/2024Jason P RhodesDirectorSell782$33.10$25,884.20 10/16/2024Dirk KerstenDirectorSell23,671$35.35$836,769.85 9/25/2024Dirk KerstenDirectorSell2,357$35.06$82,636.42 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/23/2024Dirk KerstenDirectorSell40,831$35.32$1,442,150.92 9/20/2024Dirk KerstenDirectorSell79,411$36.45$2,894,530.95 9/18/2024Oxana BeskrovnayaInsiderSell2,339$34.55$80,812.45 9/18/2024Richard William ScalzoSVPSell1,390$34.55$48,024.50 9/18/2024Susanna Gatti HighCOOSell8,976$34.41$308,864.16 9/4/2024John CoxCEOBuy32,000$33.04$1,057,280.00 6/24/2024Susanna Gatti HighCOOSell10,163$35.33$359,058.79 (Data available from 1/1/2013 forward) DYN Insider Trading Activity - Frequently Asked Questions Who is on Dyne Therapeutics' Insider Roster? The list of insiders at Dyne Therapeutics includes Carlo Incerti, Dirk Kersten, Jason P Rhodes, Johanna Friedl-Naderer, John Cox, Jonathan Mcneill, Joshua T Brumm, Oxana Beskrovnaya, Richard William Scalzo, Susanna Gatti High, Venture Fund Xi L.P. Atlas, and Wildon Farwell. Learn more on insiders at DYN. What percentage of Dyne Therapeutics stock is owned by insiders? 20.77% of Dyne Therapeutics stock is owned by insiders. Learn more on DYN's insider holdings. Which Dyne Therapeutics insiders have been buying company stock? The following insiders have purchased DYN shares in the last 24 months: Dirk Kersten ($29,999,987.50), and John Cox ($1,057,280.00). How much insider buying is happening at Dyne Therapeutics? Insiders have purchased a total of 1,746,285 DYN shares in the last 24 months for a total of $31,057,267.50 bought. Which Dyne Therapeutics insiders have been selling company stock? The following insiders have sold DYN shares in the last 24 months: Carlo Incerti ($474,045.00), Dirk Kersten ($5,256,088.14), Jason P Rhodes ($21,462,889.70), Johanna Friedl-Naderer ($1,733.16), Jonathan Mcneill ($117,370.00), Joshua T Brumm ($6,135,928.75), Oxana Beskrovnaya ($2,275,070.85), Richard William Scalzo ($1,093,157.16), Susanna Gatti High ($5,774,836.82), Venture Fund Xi L.P. Atlas ($20,162,906.51), and Wildon Farwell ($198,713.88). How much insider selling is happening at Dyne Therapeutics? Insiders have sold a total of 2,578,978 Dyne Therapeutics shares in the last 24 months for a total of $62,952,739.97 sold. Dyne Therapeutics Key ExecutivesMs. Susanna Gatti High M.B.A. (Age 56)Chief Operating Officer Compensation: $754.1kDr. Jonathan McNeill M.D. (Age 39)Chief Business Officer Compensation: $662.34kMr. John G. Cox M.B.A. (Age 61)CEO, President & Director Dr. Romesh Subramanian Ph.D. (Age 59)Co-Founder & Advisor Compensation: $565.17kMr. Richard William Scalzo M.B.A. (Age 38)Senior VP and Head of Finance & Administration 1 recent tradesMr. John Najim M.B.A.Chief Technical OfficerDr. Oxana Beskrovnaya Ph.D. (Age 63)Chief Scientific Officer Compensation: $631.08kMs. Amy Reilly (Age 50)Senior VP and Head of Corporate Communications & Investor Relations Mr. Daniel Wilson (Age 52)Senior VP & Head of Legal Ms. Kate MitchellVP & Head of Human Resources More Insider Trading Tools from MarketBeat Related Companies GRFS Insider Ownership TGTX Insider Ownership NUVL Insider Ownership LNTH Insider Ownership AXSM Insider Ownership ADMA Insider Ownership ZLAB Insider Ownership AKRO Insider Ownership PCVX Insider Ownership PTCT Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for June This page (NASDAQ:DYN) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyne Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DYN Stock Free DYN Stock Alerts